Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ellerby

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Journal of Neurochemistry|March 31, 2007
Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic miceJorge M A Oliveira, Mika B Jekabsons, Sylvia Chen, et al.
Brain Research|December 21, 2023
Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegenerationFadzai Teramayi, Joanna Bons, Madeleine Scott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 17, 2021
Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 IsoformsMaria-Daniela Cirnaru, Jordi Creus-Muncunill, Shareen Nelson, et al.
Molecular & Cellular Proteomics : MCP|June 21, 2011
Mass spectrometric identification of novel lysine acetylation sites in huntingtinXin Cong, Jason M Held, Francesco DeGiacomo, et al.
Nature Communications|December 1, 2011
Charge density waves in the graphene sheets of the superconductor CaC(6)K C Rahnejat, C A Howard, N E Shuttleworth, et al.
Neurology|October 1, 1996
Cell death mechanisms in ALSD E Bredesen, M Wiedau-Pazos, J J Goto, et al.
Human Molecular Genetics|April 11, 2015
Proteolytic cleavage of ataxin-7 promotes SCA7 retinal degeneration and neurological dysfunctionStephan J Guyenet, Shona S Mookerjee, Amy Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2005
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's diseaseKunlin Jin, Michelle LaFevre-Bernt, Yunjuan Sun, et al.
Nature Medicine|March 31, 2000
A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursorD C Lu, S Rabizadeh, S Chandra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Twenty years of therapeutic development in tauopathy mouse models: a scoping reviewVanessa F Langness, Danielle A Simmons, Tyne L M McHugh, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Journal of Neurochemistry|March 31, 2007
Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic miceJorge M A Oliveira, Mika B Jekabsons, Sylvia Chen, et al.
Brain Research|December 21, 2023
Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegenerationFadzai Teramayi, Joanna Bons, Madeleine Scott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 17, 2021
Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 IsoformsMaria-Daniela Cirnaru, Jordi Creus-Muncunill, Shareen Nelson, et al.
Molecular & Cellular Proteomics : MCP|June 21, 2011
Mass spectrometric identification of novel lysine acetylation sites in huntingtinXin Cong, Jason M Held, Francesco DeGiacomo, et al.
Nature Communications|December 1, 2011
Charge density waves in the graphene sheets of the superconductor CaC(6)K C Rahnejat, C A Howard, N E Shuttleworth, et al.
Neurology|October 1, 1996
Cell death mechanisms in ALSD E Bredesen, M Wiedau-Pazos, J J Goto, et al.
Human Molecular Genetics|April 11, 2015
Proteolytic cleavage of ataxin-7 promotes SCA7 retinal degeneration and neurological dysfunctionStephan J Guyenet, Shona S Mookerjee, Amy Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2005
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's diseaseKunlin Jin, Michelle LaFevre-Bernt, Yunjuan Sun, et al.
Nature Medicine|March 31, 2000
A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursorD C Lu, S Rabizadeh, S Chandra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Twenty years of therapeutic development in tauopathy mouse models: a scoping reviewVanessa F Langness, Danielle A Simmons, Tyne L M McHugh, et al.
Pageof 13